Global PFO Amplatzer Market

PFO Amplatzer Market Size, Share, Growth Analysis, By Product (Amplatzer PFO Occluder, Other PFO Occluders), By Application (Hospitals, Clinics), By End-User (Pediatric Patients, Adult Patients), By Region - Industry Forecast 2025-2032


Report ID: SQSG35A2066 | Region: Global | Published Date: December, 2024
Pages: 221 | Tables: 61 | Figures: 61

PFO Amplatzer Market News

  • In September 2021, Abbott announced that the FDA has approved the company's Amplatzer Talisman PFO Occlusion System to treat people with a patent foramen ovale (PFO) – who are at risk of recurrent ischemic stroke. Expanding on the success of Abbott's Amplatzer PFO Occluder, the next-generation Talisman system offers an additional 30mm device size, and all Talisman PFO occluders come pre-attached to the delivery cable, reducing preparation time for doctors. The FDA also cleared the Amplatzer Talisman Delivery Sheath, used to deliver the occluder during implantation.
  • In 2020, Abbott was the leading competitor for ASD and VSD devices. For ASD devices, Abbott offers the Amplatzer Septal Occluder, which is a minimally invasive device using transcatheter for replacement. The Amplatzer Muscular VSD Occluder is the VSD device that Abbott offers.
  • In April 2018, W. L. Gore and Associates, Inc. gotten the US FDA endorsement for its GORE CARDIOFORM Septal Occluder for PFO closure to forestall intermittent ischemic stroke.
  • In 2016, Lifetech Scientific (Shenzhen) Co., Ltd. was leading its Post Market Clinical Follow-up study for its gadget named IrisFIT PFO Occluder for the signs of PFO ailments.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global PFO Amplatzer Market size was valued at USD 128.69 million in 2023 and is poised to grow from USD 143.88 million in 2024 to USD 351.17 million by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032). 

The PFO Amplatzer Market is highly consolidated, with the existence of limited number of major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve market share and profitability. Some of the major players in the market are Abbott, WL Gore and Associates, Cardia Inc., and Occlutech among others who are driving the market. 'Abbott Laboratories (US) ', 'Boston Scientific Corporation (US) ', 'Medtronic plc (Ireland) ', 'W. L. Gore & Associates, Inc. (US) ', 'Occlutech Holding AG (Switzerland) ', 'Lifetech Scientific Corporation (China) ', 'MicroPort Scientific Corporation (China) ', 'Terumo Corporation (Japan) ', 'B. Braun Melsungen AG (Germany) ', 'Edwards Lifesciences Corporation (US) ', 'Cook Medical Inc. (US) ', 'Biotronik SE & Co. KG (Germany) '

PFO Amplatzer market is significantly determined by the high occurrence of ischemic stroke. Stroke is the second most normal reason for death on the planet. As per the American Stroke Association, 2016, every year a greater number of than 795,000 individuals in U.S. experience the ill effects of stroke, of which around 87% of stroke are ischemic strokes. Growing adoption of way of life related risk factors, such as, smoking, liquor, drugs or sedentary way of life is supposed to surge the risk of stroke occurrence.

PFO Amplatzer Occluder demand is significantly determined by the high occurrence of ischemic stock. Stroke is the second most normal reason for death on the planet. Growing adoption of standard of living related risks, such as, smoking, liquor, drugs or sedentary way of life is supposed to surge the risk of stroke. Moreover, expanding number of congenital heart illness is supposed to push development of the PFO closure devices.

North America holds the dominant market share credited to the high occurrence of ischemic stroke in the region. Food consumption habits and changing lifestyle among consumers coupled with high disposable income is causing an growing percentage of cardiovascular diseases and heart attacks. These ailments are one of the key factors boosting the growth of the global PFO Amplatzers in the forecast timeframe.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global PFO Amplatzer Market

Report ID: SQSG35A2066

$5,300
BUY NOW GET FREE SAMPLE

This site uses cookies. See Our Privacy And Policy For More info.